WHO-유니콘뉴스

뉴스기사물 (10)

2024-08-16 00:00:30

Riskified Appoints David Meredith to Board of Directors

신상품경제 동향 NEW YORK--(Business Wire / Korea Newswire)--“We are thrilled to welcome David Meredith to our Board of Directors,” said Eido Gal, CEO and Co-Founder of Riskified. “David brings extensive experience in corporate strategy, customer acquisition...

2024-08-16 00:00:28

AutoChips Integrated Multiple VeriSilicon’s IPs in Its Intelligent Cockpit Domain Control SoC

신상품경제 동향 SHANGHAI--(Business Wire / Korea Newswire)--VeriSilicon (688521.SH) today announced that AutoChips, an automotive electronic chip design company, has adopted VeriSilicon’s high-performance IP portfolio in its new generation intelligent cockpit domain control SoC AC8025, including Neural...

2024-08-14 00:00:36

LG화학, 영아용 6가 백신 임상 2상 본격화… 혼합백신 국산화 프로젝트 박차

서울 서울--(뉴스와이어)--LG화학이 전량 수입에 의존하고 있는 영아용 혼합백신 국산화 추진에 박차를 가한다. LG화학은 ‘정제 백일해(acellular Pertussis, aP)’ 기반 6가 혼합백신 ‘LR20062’의 임상 2상을 해외에서 실시하며, 본격적인 시험자 모집 준비에 들어간다고 13일 밝혔다. 1상을 성공적으로 마치고...

2024-08-14 00:00:22

Brandnew Lab Concludes Successful Symposium for NUVOEN Launch

서울 SEOUL--(Korea Newswire)--On August 13, Brandnew Lab (https://brandnewlab.co.kr) announced the successful launch of its highly anticipated clinical-use ampoule line, NUVOEN, at the symposium that took place on July 22 at the Brand New Clinic(https://brandnewclinic.com) in...

2024-08-14 00:00:20

Galderma Receives U.S. FDA Approval for Nemluvio® (nemolizumab) for Adult Patients Living With Prurigo Nodularis

서울 ZUG, SWITZERLAND--(Business Wire / Korea Newswire)--Galderma today announced that the U.S. Food and Drug Administration (FDA) has approved Nemluvio® (nemolizumab) as a pre-filled pen for subcutaneous injection for the treatment of adults with prurigo...

2024-08-14 00:00:20

UAE’s Technology Innovation Institute Revolutionizes AI Language Models With New Architecture

서울 ABU DHABI, UNITED ARAB EMIRATES--(Business Wire / Korea Newswire)--The Technology Innovation Institute (TII), a leading global scientific research center and the applied research pillar of Abu Dhabi’s Advanced Technology Research Council (ATRC), has released...

2024-08-10 00:01:27

BeiGene Enters Next Phase of Global Growth with Announcement of Second Quarter 2024 Financial Results and Corporate Updates

SAN MATEO, CALIF.--(Business Wire / Korea Newswire)--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced results from the second quarter 2024 and corporate updates that strengthen the Company for...

2024-08-10 00:01:27

Nichi BRITE Beta glucan as an onco-nutrition supplement in pancreatic cancer; Encouraging clinical results reported by Chikamori Hospital, Japan.

TOKYO--(Business Wire / Korea Newswire)--Nichi BRITE Beta glucan administration resulted in enhancement of immunity followed by reduction in biomarkers of pancreatic cancer and that of its recurrence in patients undergoing surgical resection of malignant...

2024-08-10 00:01:26

Parse Biosciences Partners with Taiwan-based Prisma Biotech to Extend Reach in Asia

SEATTLE--(Business Wire / Korea Newswire)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced an agreement with Taipei-based Prisma Biotech to broaden Parse’s reach in Taiwan and across Asia-Pacific....

2024-08-10 00:01:25

파스 바이오사이언스, 대만 프리즈마 바이오테크와 제휴해 아시아 지역 진출 확대

건강제휴회계/세무해외 시애틀--(Business Wire / 뉴스와이어)--접근성이 뛰어나고 확장 가능한 단일 세포 시퀀싱 솔루션의 선도적 공급업체인 파스 바이오사이언스(Parse Biosciences)는 타이베이에 본사를 둔 프리즈마 바이오텍(Prisma Biotech)과 대만 및 아시아 태평양 지역에서 파스의 사업 범위를 확대하기 위한 협약을 체결했다고...

API